NO983451L - FremgangsmÕte for hemming av colontumorer - Google Patents

FremgangsmÕte for hemming av colontumorer

Info

Publication number
NO983451L
NO983451L NO983451A NO983451A NO983451L NO 983451 L NO983451 L NO 983451L NO 983451 A NO983451 A NO 983451A NO 983451 A NO983451 A NO 983451A NO 983451 L NO983451 L NO 983451L
Authority
NO
Norway
Prior art keywords
procedure
inhibiting colon
colon tumors
inhibiting
rog
Prior art date
Application number
NO983451A
Other languages
English (en)
Other versions
NO983451D0 (no
Inventor
Maria L Brandi
Francesco Tonelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO983451L publication Critical patent/NO983451L/no
Publication of NO983451D0 publication Critical patent/NO983451D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Fremgangsmåte for hemming av coloncancer omfatter administrering til et pattedyr som har behov for dette av en effektiv mengde av en forbindelse som har formel (I),. der Rog Ruavhengig av hverandre er hydrogen, -CH, (a), eller (b), hvori Ar eventuelt er substituert fenyl; RJ blir valgt fra gruppen bestående av pyrrolidin, heksametylenimin og piperidin; eller et farmasøytisk akseptabelt salt eller solvat derav.
NO983451A 1996-01-29 1998-07-27 FremgangsmÕte for hemming av colontumorer NO983451D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
NO983451L true NO983451L (no) 1998-07-27
NO983451D0 NO983451D0 (no) 1998-07-27

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983451A NO983451D0 (no) 1996-01-29 1998-07-27 FremgangsmÕte for hemming av colontumorer

Country Status (19)

Country Link
EP (1) EP0921799A4 (no)
JP (1) JP2000503994A (no)
KR (1) KR19990082054A (no)
CN (1) CN1209745A (no)
AR (1) AR010978A1 (no)
AU (1) AU707892B2 (no)
BR (1) BR9700778A (no)
CO (1) CO4761062A1 (no)
CZ (1) CZ235498A3 (no)
EA (1) EA001104B1 (no)
ID (1) ID15917A (no)
IL (1) IL125521A (no)
MX (1) MX9806036A (no)
NO (1) NO983451D0 (no)
NZ (1) NZ331105A (no)
PL (1) PL328147A1 (no)
TW (1) TW446560B (no)
WO (1) WO1997026877A1 (no)
YU (1) YU2397A (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
ZA948025B (en) * 1993-10-15 1996-04-15 Lilly Co Eli Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
CN1209745A (zh) 1999-03-03
KR19990082054A (ko) 1999-11-15
EP0921799A4 (en) 2002-03-13
EA199800677A1 (ru) 1999-02-25
PL328147A1 (en) 1999-01-18
YU2397A (en) 1999-11-22
IL125521A (en) 2001-11-25
ID15917A (id) 1997-08-21
EA001104B1 (ru) 2000-10-30
WO1997026877A1 (en) 1997-07-31
AU707892B2 (en) 1999-07-22
NO983451D0 (no) 1998-07-27
AU2123997A (en) 1997-08-20
AR010978A1 (es) 2000-08-02
JP2000503994A (ja) 2000-04-04
BR9700778A (pt) 1998-10-06
EP0921799A1 (en) 1999-06-16
MX9806036A (es) 1998-11-29
CO4761062A1 (es) 1999-04-27
CZ235498A3 (cs) 1999-02-17
NZ331105A (en) 2000-06-23
TW446560B (en) 2001-07-21
IL125521A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
EA200100766A1 (ru) Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов
MY116915A (en) Substituted indazole analogs
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
NO944927L (no) Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
RU94045846A (ru) Применение производных бензотиофена для ингибирования тромбина
NO944914L (no) Fremgangsmåte for å inhibere autoimmunsykdommer
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
RU94044490A (ru) Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани
NO944926L (no) Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO944930L (no) Hemming av dysfunksjonell uterin blödning
KR20000005379A (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
NO20010654D0 (no) Ny anvendelse av taxoidderivater
NO944924L (no) Fremgangsmåter for inhibering av Turner's syndrom
NO975580L (no) Fremgangsmåte for å inhibere melanom
NO973367L (no) Fremgangsmåte for å inhibere miljömessige östrogen
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
NO975738L (no) Modulering av kalsiumkanaler
NO981578L (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
NO973609L (no) Fremgangsmåte for å inhibere effektene av IL-6
NO983451L (no) FremgangsmÕte for hemming av colontumorer
NO970783L (no) Fremgangsmåte for å hindre endometrialkreft
NO983452L (no) FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer)
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
NO971029L (no) Fremgangsmåter for hemming av endometriale metoser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application